Startups
RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. We enable biology at scale.
Overview
Location
United States, Massachusetts, Watertown
Employees
11-50
Total raised
$57M
Founded date
2017
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Aug 30, 2018 | Seed round | $7M |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 7, 2021 | China Digest: RootPath raises $50m; ByteDance leads Haoxinqing’s $31m Series C | China’s CDH Investments and Sky9 Capital have led a $50 million Series B round for biotech firm RootPath Genomics, while healthcare firm Haoxinqing has secured 200 million yuan ($31 million) in a Series C round led by ByteDance. CDH, Sky9 l... |
| Jan 7, 2020 | RootPath Scores $11M in Series A | CAMBRIDGE, MA, Preclinical-stage biotechnology company announced a $11 million Series A funding round. >> Click here for more funding data on RootPath >> To export RootPath funding data to PDF and Excel, click here RootPa... |
| Jan 6, 2020 | RootPath Raises $11 Million Series A | RootPath, a preclinical-stage biotechnology company aiming to enable personalized, highly-potent T cell therapy powered by its proprietary Synthetic Immunology Platform™, today announced a $11 million Series A funding round. New investors i... |
| Aug 31, 2018 | Sequoia China leads $7m seed round for Cambridge-based biotech firm RootPath | Premium RootPath, a Cambridge-based biotechnology company, has announced the closing of a $7 million seed funding round led by Sequoia China. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber?... |
| Aug 30, 2018 | RootPath Secures $7M Seed Financing | CAMBRIDGE, MA, RootPath today announced a $7 million seed funding. >> Click here for more funding data on RootPath >> To export RootPath funding data to PDF and Excel, click here RootPath, a Cambridge-based biotechnology ... |
| Aug 30, 2018 | RootPath Raises $7M in Seed Funding Round | RootPath, a Cambridge, MA-based biotechnology company developing a personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy, raised $7m in seed funding. The round was led by Sequoia China with participat... |
| Aug 30, 2018 | RootPath Raises $7 Million Seed Round | RootPath, a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy, today announced a $7 million seed funding round led by Sequoia China with... |
| Aug 30, 2018 | Daily funding roundup - August 30, 2018 | Openland is backed by $2.25M by 30 investors, Phrasee Lands $4M for AI-Powered Copywriting Phrasee:Phrasee is AI that specializes in language generation for email marketing, push, and Facebook copy. Having studied millions of words, phrases... |
Reviews 0
FAQ about RootPath
When was RootPath founded?
RootPath was founded in 2017.
How much funding has RootPath raised?
RootPath has raised $57M in total across 2 funding rounds.
What funding rounds has RootPath raised?
Parsers VC lists 2 funding rounds of RootPath, among them a seed round of $7M on Aug 30, 2018.
What has the press written about RootPath?
Parsers VC has collected 9 articles mentioning RootPath, among them “China Digest: RootPath raises $50m; ByteDance leads Haoxinqing’s $31m Series C” (Sep 7, 2021) and “RootPath Scores $11M in Series A” (Jan 7, 2020).
Is RootPath still active?
Yes, RootPath is active; its latest activity on Parsers VC dates from Sep 7, 2021.